Iovance Biotherapeutics Inc IOVA:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 12:26 PM EDT
10.06quote price arrow down-0.27 (-2.57%)
Volume
1,599,132
52 week range
3.21 - 18.33
Loading...
  • Open10.38
  • Day High10.38
  • Day Low10.01
  • Prev Close10.33
  • 52 Week High18.33
  • 52 Week High Date02/28/24
  • 52 Week Low3.21
  • 52 Week Low Date10/19/23

Key Stats

  • Market Cap2.817B
  • Shares Out279.83M
  • 10 Day Average Volume7.06M
  • Dividend-
  • Dividend Yield-
  • Beta0.82
  • YTD % Change23.86

KEY STATS

  • Open10.38
  • Day High10.38
  • Day Low10.01
  • Prev Close10.33
  • 52 Week High18.33
  • 52 Week High Date02/28/24
  • 52 Week Low3.21
  • 52 Week Low Date10/19/23
  • Market Cap2.817B
  • Shares Out279.83M
  • 10 Day Average Volume7.06M
  • Dividend-
  • Dividend Yield-
  • Beta0.82
  • YTD % Change23.86

RATIOS/PROFITABILITY

  • EPS (TTM)-1.81
  • P/E (TTM)-5.56
  • Fwd P/E (NTM)-7.58
  • EBITDA (TTM)-441.088M
  • ROE (TTM)-66.77%
  • Revenue (TTM)1.904M
  • Gross Margin (TTM)-846.22%
  • Net Margin (TTM)-23,615.70%
  • Debt To Equity (MRQ)0.15%

EVENTS

  • Earnings Date08/06/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Iovance Biotherapeutics Inc

 

Profile

MORE
Iovance Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company develops and delivers tumor infiltrating lymphocyte (TIL), therapies for patients with solid tumor cancers. Its lead product candidate, Amtagvi (lifileucel), is a tumor-derived autologous T cell immunotherapy indicated for the treatment of adult patients with unresectable or metastatic melanoma previously treated with a PD-1 blocking antibody, and if BRAF V600 mutation positive, a BRAF...
Iain Dukes Ph.D.
Independent Chairman of the Board
Frederick Vogt J.D., Ph.D.
Interim President, Interim Chief Executive Officer, General Counsel, Corporate Secretary
Igor Bilinsky Ph.D.
Chief Operating Officer
Jean-Marc Bellemin
Chief Financial Officer
Address
825 INDUSTRIAL ROAD, 4TH FLOOR
San Carlos, CA
94070
United States

Top Peers

SYMBOLLASTCHG%CHG
APGE
Apogee Therapeutics Inc
47.00-0.87-1.82%
RNA
Avidity Biosciences Inc
28.65-0.97-3.27%
XENE
Xenon Pharmaceuticals Inc
38.44-0.36-0.94%
IDYA
IDEAYA Biosciences Inc
40.98-0.40-0.97%
CLDX
Celldex Therapeutics Inc
37.27-0.83-2.18%